Rapid Micro Biosystems (RPID) Return on Sales (2020 - 2026)

Rapid Micro Biosystems has disclosed Return on Sales across 7 years of filings, most recently posting 0.02% for Q1 2026.

• Return on Sales for Q1 2026 came in at 0.02%, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.01% (changed 0.0% YoY), and the FY2025 annual result was 0.01%, changed 0.0% from the prior year.
• Return on Sales came in at 0.02% for Q1 2026 at Rapid Micro Biosystems, down from 0.01% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.01% in Q4 2025 to a low of 0.04% in Q4 2022.
• The 5-year median for Return on Sales is 0.02% (2024), against an average of 0.02%.
• Across the five-year window, Return on Sales fell 1 bps in 2022 and grew 2 bps in 2023, its largest moves.
• Rapid Micro Biosystems' Return on Sales stood at 0.04% in 2022, then soared by 53 bps to 0.02% in 2023, then surged by 33 bps to 0.01% in 2024, then gained by 6 bps to 0.01% in 2025, then plunged by 61 bps to 0.02% in 2026.
• The last three Return on Sales figures came in at 0.02% (Q1 2026), 0.01% (Q4 2025), and 0.01% (Q3 2025), per Business Quant data.